Metraipolis › archive › dc_e6a82d2be9fb

Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma — Europe PMC PMID:41291768

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41291768
DOI
10.1186/s12935-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-08T06:52:22.885Z
SHA-256 of the archived text
cc8fe5752e5145e440893b0a4897de1201f84c157b5ed49da800e75d243cb919
Stable URL of this page
https://metraipolis.com/documento/dc_e6a82d2be9fb

How to cite

Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma — Europe PMC PMID:41291768 — Europe PMC (en), https://europepmc.org/article/MED/41291768 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e6a82d2be9fb (Metraipolis archive dc_e6a82d2be9fb, sha256 cc8fe5752e5145e440893b0a4897de1201f84c157b5ed49da800e75d243cb919)
BibTeX
@misc{dce6a82d2be9fb,
  title = {Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma — Europe PMC PMID:41291768},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41291768},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e6a82d2be9fb; sha256 cc8fe5752e5145e440893b0a4897de1201f84c157b5ed49da800e75d243cb919},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41291768. Agents can read the archived copy with the MCP tool read_document.